WHIPPANY, N.J.--(BUSINESS WIRE)--Image Solutions, Inc. (ISI), a leader in providing software and services to streamline the drug development and regulatory approval process, today announced that NovaRx, a privately held biopharmaceutical company based in San Diego, California, has selected its regulatory submission package. The company has purchased eCTDXPress, ISI’s flagship electronic submission software, as well as ISIWriter, the industry’s most robust set of global authoring templates for developing submission-ready documents.
